Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer
NCT ID: NCT03855423
Last Updated: 2019-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12 participants
INTERVENTIONAL
2019-02-18
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Clinical Trial With Tocotrienol on Breast Cancer
NCT01157026
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
NCT06214195
Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
NCT01596530
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
NCT05103644
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
NCT01151215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tocotrienol-rich Fraction (TRF)
Pre-operative patients will be receiving TRF at different doses assigned to them in a cohort of 3 patients at each level.
Tocotrienol-rich Fraction (TRF)
TRF consists of alpha, gamma and delta tocotrienols in addition to small amount of alpha-tocopherol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tocotrienol-rich Fraction (TRF)
TRF consists of alpha, gamma and delta tocotrienols in addition to small amount of alpha-tocopherol
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Life expectancy of at least 3 months
* Adequate organ function
* No allergy to Vitamin E and TRF
* Provides consent to participate in trial and adhere to the study protocol
Exclusion Criteria
* Uncontrolled concurrent illness
* Pregnant / breast feeding women
* Patients who are unable or unwilling to take Tocotrienols, herbal remedies, or non-prescription medications
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malaysia Palm Oil Board
OTHER_GOV
Nur Aishah Mohd Taib
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nur Aishah Mohd Taib
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nur Aishah Taib, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Malaya Medical Center
Kuala Lumpur, , Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nur Aishah Taib, MBBS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
853.4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.